In a 6-year-old boy with no bleeding history, what is the significance of a von Willebrand factor antigen level of 62% with a normal von Willebrand factor activity of 80%, and normal factor VIII, prothrombin time (PT), and activated partial thromboplastin time (aPTT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

These laboratory findings are normal variants that do not indicate von Willebrand disease and require no treatment or further investigation in this asymptomatic child.

Interpretation of Laboratory Results

The key finding here is a mildly reduced VWF antigen (62%) with normal VWF activity (80%), which creates a VWF activity-to-antigen ratio of approximately 1.3 (80/62). This pattern does not fit any recognized type of VWD 1.

Why This is NOT von Willebrand Disease

The three diagnostic criteria for VWD must be met 1:

  1. Personal history of excessive mucocutaneous bleeding - ABSENT in this child
  2. Family history of bleeding - NOT mentioned/likely absent
  3. Reduced VWF levels - VWF activity is normal at 80%

Critical point: VWD diagnosis requires both VWF antigen AND activity to be reduced, typically with a proportional relationship. When VWF activity is normal or higher than antigen (as in this case), VWD is effectively ruled out 1.

Age-Related VWF Levels in Children

The mildly reduced VWF antigen of 62% is entirely expected for a 6-year-old child. Research demonstrates that VWF levels increase with age 2:

  • Children <3 years: median VWF:Ag 81%
  • Children 3-6 years: median VWF:Ag 82%
  • Children 7-10 years: median VWF:Ag 90%
  • Children 11-18 years: median VWF:Ag 100%

In the 2-6 year age group, 5% of healthy children have VWF:Ag <50%, yet only 1.8% had abnormal bleeding scores and only 2.5% experienced surgical bleeding 2. This child's VWF:Ag of 62% falls well within the normal range for age.

Clinical Significance

The absence of bleeding history is paramount. Even children with true low VWF (defined as VWF:Ag <50%) rarely experience bleeding complications. In a large prospective study of 1,399 children undergoing tonsillectomy, low VWF levels did not correlate with postoperative bleeding 2.

The normal PT, aPTT, and Factor VIII further confirm no clinically significant hemostatic defect exists.

Management Recommendations

No intervention is needed:

  • No treatment required
  • No activity restrictions
  • No prophylaxis needed for procedures
  • No repeat testing necessary given the normal VWF activity and absence of bleeding

Reassurance to family: Explain that VWF levels naturally increase as children grow, and this child's slightly lower antigen level with normal activity represents normal developmental variation, not disease.

Only consider retesting if: The child develops a significant bleeding history in the future (excessive bruising, prolonged bleeding from minor cuts, heavy nosebleeds requiring medical intervention, or problematic bleeding with dental procedures or surgery). Even then, the normal VWF activity makes VWD highly unlikely 1.

Related Questions

Can prothrombin time (PT) and activated partial thromboplastin time (aPTT) be slightly elevated in a teenage patient with low von Willebrand factor level?
In a 6-year-old boy with recurrent epistaxis, von Willebrand factor antigen 62%, von Willebrand factor activity 80%, normal factor VIII, normal prothrombin time (PT) and activated partial thromboplastin time (aPTT), what is the best management approach?
In a 4‑month‑old infant with non‑traumatic petechiae on the medial aspects of both femurs and laboratory findings of normal platelet count, normal prothrombin time (PT), normal activated partial thromboplastin time (aPTT), normal von Willebrand factor (vWF) antigen, reduced von Willebrand factor activity (~40 %), and normal factor VIII, what is the appropriate next step in management?
What does a normal von Willebrand factor (vWF) result indicate regarding von Willebrand disease and its management?
What is the significance of a prolonged activated partial thromboplastin time (aPTT) in von Willebrand disease (VWD) and how should it be evaluated and managed?
If the source patient cannot be tested after a needlestick injury, what steps should I take for post‑exposure prophylaxis and follow‑up?
What is the current recommendation for phenobarbital use as a first‑line therapy in adult patients with moderate‑to‑severe alcohol withdrawal, including dosing, administration schedule, and monitoring parameters?
What laboratory findings indicate dehydration in a patient with type 2 diabetes mellitus who is taking losartan and tirzepatide?
With elevated C‑peptide, C‑reactive protein (CRP), and erythrocyte sedimentation rate (ESR), a normal antinuclear antibody (ANA) test, and negative autoimmune diabetes profile including glutamic acid decarboxylase‑65 (GAD‑65) antibodies, what are the next diagnostic and management steps?
How should I manage a patient with a lipid panel showing total cholesterol 319 mg/dL, triglycerides 328 mg/dL, HDL cholesterol 55 mg/dL, LDL cholesterol 264 mg/dL, VLDL cholesterol 65.6 mg/dL, LDL/HDL ratio 4.8, non‑HDL cholesterol 264 mg/dL, and cholesterol/HDL ratio 5.8?
How should a 60‑day‑old third‑degree abdominal burn with fine crusts, erythema, blisters, fibrous scars, and exudative areas be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.